Aspirin is already given to people who have had a stroke or transient ischaemic attack (TIA), often called a 'mini-stroke', to prevent further strokes after they have been assessed in hospital and in the longer-term, reducing the subsequent stroke risk by about 15 per cent.
However, based on a previous study, the team suspected that the benefits of more immediate treatment with aspirin could be much greater.
"The risk of a major stroke is very high immediately after a TIA or a minor stroke (about 1,000 times higher than the background rate), but only for a few days," said lead researcher Peter Rothwell, a stroke expert from the University of Oxford in the UK.
"We suspected that the early benefit might be much greater. If so, taking aspirin as soon as possible after 'warning symptoms' event could be very worthwhile," he said.
The team from Oxford, University Medical Centre Utrecht in the Netherlands, University Duisburg-Essen in Germany and Lund University in Sweden revisited the individual patient data from twelve trials (about 16,000 people) of aspirin for long-term secondary prevention - that is, to prevent a further stroke - and data on about 40,000 people from three trials of aspirin in treatment of acute stroke.
Rather than the 15 per cent overall reduction in longer-term risk reported previously in these trials, aspirin reduced the early risk of a fatal or disabling stroke by about 70-80 per cent over the first few days and weeks.
"Our findings confirm the effectiveness of urgent treatment after TIA and minor stroke - and show that aspirin is the most important component," Rothwell said.
"Immediate treatment with aspirin can substantially reduce the risk and severity of early recurrent stroke. This finding has implications for doctors, who should give aspirin immediately if a TIA or minor stroke is suspected, rather than waiting for specialist assessment and investigations," he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
